MARKET

GMED

GMED

Globus Med Inc
NYSE

Real-time Quotes | Nasdaq Last Sale

57.39
-0.33
-0.57%
Closed 16:33 07/05 EDT
OPEN
56.63
PREV CLOSE
57.72
HIGH
57.51
LOW
55.13
VOLUME
423.39K
TURNOVER
--
52 WEEK HIGH
84.23
52 WEEK LOW
52.60
MARKET CAP
5.84B
P/E (TTM)
42.06
1D
5D
1M
3M
1Y
5Y
Is It Too Late To Consider Buying Globus Medical, Inc. (NYSE:GMED)?
While Globus Medical, Inc. ( NYSE:GMED ) might not be the most widely known stock at the moment, it saw significant...
Simply Wall St. · 23h ago
Why Globus Medical (GMED) is a Top Growth Stock for the Long-Term
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Zacks · 06/27 13:45
Stocks That Hit 52-Week Lows On Monday
  During Monday's trading, 1214 companies set new 52-week lows.
Benzinga · 06/13 16:18
Globus Medical's Return On Invested Capital Insights
Pulled from Benzinga Pro data, Globus Medical (NYSE:GMED) posted Q1 earnings of $38.08 million, an increase from Q4 of 152.11%. Sales dropped to $230.55 million, a 7.79% decrease between quarters.
Benzinga · 06/10 15:49
Why Is Globus Medical (GMED) Up 1.7% Since Last Earnings Report?
Globus Medical (GMED) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Zacks · 06/09 15:30
Here's Why Investors Should Retain Globus Medical (GMED) Now
Globus Medical's (GMED) strong international growth and meaningful product launches raise investors' optimism.
Zacks · 06/07 16:21
The total return for Globus Medical (NYSE:GMED) investors has risen faster than earnings growth over the last five years
Globus Medical, Inc. ( NYSE:GMED ) shareholders might be concerned after seeing the share price drop 12% in the last...
Simply Wall St. · 06/06 15:13
Globus Medical (GMED) Completes First Cases With Excelsius3D
Globus Medical's (GMED) Excelsius3D, when combined with ExcelsiusGPS, facilitates greater implant placement accuracy, lowers radiation exposure and reduces operative times.
Zacks · 05/19 16:03
More
No Data
Learn about the latest financial forecast of GMED. Analyze the recent business situations of Globus Med Inc through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 14 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

21.43%Strong Buy
42.86%Buy
28.57%Hold
7.14%Under-perform
0.00%Sell
Analyst Price Target
The average GMED stock price target is 76.08 with a high estimate of 100.00 and a low estimate of 65.00.
High100.00
Average76.08
Low65.00
Current 57.39
EPS
Actual
Estimate
0.140.280.420.56
Q2 2021
Q3 2021
Q4 2021
Q1 2022
Q2 2022
Institutional Holdings
Institutions: 434
Institutional Holdings: 74.01M
% Owned: 72.73%
Shares Outstanding: 101.75M
TypeInstitutionsShares
Increased
142
3.67M
New
40
586.72K
Decreased
110
2.23M
Sold Out
37
283.38K
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Medical Equipment, Supplies & Distribution
-0.16%
Healthcare Equipment & Supplies
-0.07%
Key Executives
Chairman/Executive Director
David Paul
President/Chief Executive Officer/Director
Daniel Scavilla
Chief Financial Officer/Senior Vice President
Keith Pfeil
Senior Vice President/General Counsel/Secretary
Kelly Huller
Independent Director
David Davidar
Independent Director
Robert Douglas
Independent Director
Daniel Lemaitre
Independent Director
Ann Rhoads
Independent Director
James Tobin
Independent Director
Stephen Zarrilli
No Data
No Data
About GMED
Globus Medical, Inc. is a medical device company. It is focused on implants that promote healing in patients with musculoskeletal disorders, including the use of a robotic guidance and navigation system and products to treat orthopedic traumas. It groups its products into two categories: Musculoskeletal Solutions and Enabling Technologies. Its Musculoskeletal Solutions consist primarily of implantable devices, biologics, accessories, and surgical instruments used in a range of spinal, orthopedic and neurosurgical procedures. Its orthopedic trauma solutions are designed to treat a variety of orthopedic fracture patterns and patient anatomies in the upper and lower extremities as well as the hip. Its Enabling Technologies are comprised of imaging, navigation, and robotics (INR) solutions for assisted surgery. It offers solutions that facilitate both open and minimally invasive surgery (MIS) techniques. It includes traditional fusion implants, such as pedicle screw and rod systems.

Webull offers kinds of Globus Medical Inc stock information, including NYSE:GMED real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, GMED stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading GMED stock methods without spending real money on the virtual paper trading platform.